The human genome is three billion letters of code, and each person has millions of variations. While no human can realistically sift through all that code, computers can.
Tag: genomic analysis
Same same but different
A method for detecting intraspecies genomic diversity of uncultivated bacterial DNA has been developed. This enhanced MAG method’s ability to detect previously overlooked variations focuses on the DNA sequence and structural traits of the genome. The spectrum of microdiversity in environmental bacterial genomes has been found to be broader than expected.
National Researcher of the Year 2022 Decodes Drug Resistance in Animals – A Step towards Sustainable Solutions
Chula Veterinary Lecturer and “National Outstanding Researcher 2022” has revealed the genetic code that causes drug resistance in animals that affects human health, animals, and the environment, and suggests comprehensive solutions under the concept “One Health”.
Height May Be Risk Factor for Multiple Health Conditions
A large genetic study by the U.S. Department of Veteran Affairs’ Million Veteran Program (MVP)) has found that a person’s height may affect their risk for several common health conditions in adulthood.
Corn’s genetic diversity on display in new genome study
A new study details the genomes of 26 lines of corn from across the globe. The genomes can help scientists piece together the puzzle of corn genetics. Using these new genomes as references, plant scientists can better select for genes likely to lead to better crop yields or stress tolerance.
Chicago and Rush partner to detect new strains of COVID-19 with new advanced lab
Rush University Medical Center is opening an advanced molecular laboratory that will examine COVID-19 samples from across the city to detect new strains of the virus for the Chicago Department of Public Health
Identification of Tamoxifen Resistance Markers Can Play Role in Breast Cancer Treatment Planning
In a recent study, researchers from Rutgers University explored the therapeutic response to Tamoxifen, a drug that blocks the activity of estrogen to the breast, in estrogen-receptor (ER) positive breast cancer by using a computational framework to predict treatment resistance based on behavior of molecular pathways.
Improving genomic analysis website
A website used by more than 20,000 scientists to analyze their genomic data is getting an upgrade, thanks to a four-year, nearly $870,000 National Institutes of Health grant.
Researchers mine data and connect the dots about processes driving neuroblastoma
Researchers have used insight from a comprehensive genomic analysis of neuroblastoma to learn about the process driving one of the most common childhood solid tumors.
UVA pioneers study of genetic diseases with quantum computers
Scientists are harnessing the mind-bending potential of quantum computers to help us understand genetic diseases – even before quantum computers are a thing. ]
Rutgers Cancer Institute Researchers Identify Novel Gene Associated with Prognosis in Aggressive form of Ovarian Cancer
Investigators at Rutgers Cancer Institute of New Jersey have determined that an overabundance of a novel gene known as ADNP in an aggressive form of ovarian cancer may serve as a prognostic tool.